Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

UK: Bionema unveils £500M growth plan

Bionema Group has unveiled an ambitious $566 million growth projection over the next 5–10 years. This projection reflects the company's expansion in biopesticides, biofertilizers, and biostimulants via its formulation technology platforms. This initiative aligns with the global shift toward sustainable agriculture, offering farmers natural alternatives to chemical pesticides and fertilizers to enhance crop health, yield, and soil regeneration.

Unlike conventional agricultural startups focusing on a single innovation or technology, Bionema is developing ten products, including bioinsecticides, biofungicides, bionematicides, and molluscicides. These products will use microencapsulated and WDG formulations to achieve a 20-40% increase in efficacy compared to traditional pesticides or biocontrol products.

Additionally, it is developing innovative biofilm-based biofertilizers worth $961,000, funded by the Department for Environment, Food & Rural Affairs' Farming Innovation Program Nutrient Management Competition. This project is part of Defra's Farming Innovation Program, delivered in partnership with Innovate UK, to reduce the use of synthetic fertilizer and achieve net zero.

Dr. Minshad Ansari, CEO and Founder of Bionema Group, said, "With increasing restrictions on chemical pesticides and the urgent need for sustainable farming solutions, our mission is clear: to equip farmers with cutting-edge biological technologies that are both effective and environmentally friendly."

An innovative model for rapid market adoption
Bionema's technology development and commercialisation model is designed to accelerate global market penetration through licensing and technology transfers, strategic divestment and acquisitions, and global market expansion.

R&D and proprietary technologies
Bionema has a strong R&D foundation, leading to the development of multiple high-impact biological solutions, including five filed patents, those being Entomopathogenic nematodes (EPNs), beneficial fungi and bacteria, biofilm based biofertilizers, Microencapsulated and WDG (Water-Dispersible Granules) formulations, Carbon-reduction technology via systemic molluscicides, and Marine Metabolites.

Global expansion and regulatory acceleration
Bionema is actively advancing regulatory approvals and commercialisation across multiple regions, driving growth through scaling biopesticide and biofertiliser production to meet the rising global demand, accelerating regulatory approvals with EU, US, New Zealand, Australia, Latin America, and Asia authorities, and building strategic industry partnerships to distribute Bionema's next-generation biocontrol solutions at scale.

Dr Ansari added: "We are committed to making biological solutions the first choice for farmers globally. By leading the way in biopesticides and biofertilizers, we are shaping the future of sustainable agriculture".

Stephen Ford Bionema's CTO said, "Our growth plan is ambitious; however, I cannot count how many times I've been told it can't be done, only for us to discover a pathway forward. If there is one thing I know, standing still is equivalent to going backwards."

For more information:
Bionema
Room Number 009, Institute of Life Science 1, Singleton Park, Swansea University, Swansea, SA2 8PP
Tel.: +44 (0) 1792 606916
info@bionema.com
bionema.com